Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Recordati Industria Chimica e Farmaceutica SPA ( (IT:REC) ) just unveiled an announcement.
Recordati announced an update on its share buyback program, which began on April 30, 2025, following a resolution by the Shareholders’ Meeting. The program is intended to purchase shares for stock option and performance share plans for the company’s management. During the period from June 2 to June 6, 2025, Recordati purchased 70,709 ordinary shares, bringing its total holdings to 3,360,825 shares, representing 1.607% of its share capital.
The most recent analyst rating on (IT:REC) stock is a Hold with a EUR51.00 price target. To see the full list of analyst forecasts on Recordati Industria Chimica e Farmaceutica SPA stock, see the IT:REC Stock Forecast page.
More about Recordati Industria Chimica e Farmaceutica SPA
Recordati is an international pharmaceutical group listed on the Italian Stock Exchange, with origins in a family pharmacy in Northern Italy. The company provides therapeutic options in specialty and general medicine, as well as rare diseases, and operates in about 150 countries across the EMEA, Americas, and APAC regions.
Average Trading Volume: 398,031
Technical Sentiment Signal: Strong Buy
Current Market Cap: €11.34B
See more insights into REC stock on TipRanks’ Stock Analysis page.